Evidence map›Paper›PMID 40289132›Full record

ArticleBMC biology2025

Long-term in vivo immune tracking nanoplatform based on Ag

Jielin Wang, Zilu Huang, Yongbo Wu, Xiaofang Jiang, Yanhong Ji, Kevin Braeckmans, Meng Wang, Lin Wang, Wei R Chen, Yunfei Xia and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Jielin WangGuangdong Basic Research Center of Excellence for Structure and Fundamental Interactions of Matter, Guangdong Provincial Key Laboratory of Quantum Engineering and Quantum Materials, School of Physics, South China Normal University, Guangzhou, 510006, China. wang@m.scnu.edu.cn.
Zilu HuangState Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China.
Yongbo WuGuangdong Basic Research Center of Excellence for Structure and Fundamental Interactions of Matter, Guangdong Provincial Key Laboratory of Quantum Engineering and Quantum Materials, School of Physics, South China Normal University, Guangzhou, 510006, China.
Xiaofang JiangGuangdong Basic Research Center of Excellence for Structure and Fundamental Interactions of Matter, Guangdong Provincial Key Laboratory of Quantum Engineering and Quantum Materials, School of Physics, South China Normal University, Guangzhou, 510006, China.
Yanhong JiGuangdong Basic Research Center of Excellence for Structure and Fundamental Interactions of Matter, Guangdong Provincial Key Laboratory of Quantum Engineering and Quantum Materials, School of Physics, South China Normal University, Guangzhou, 510006, China.
Kevin BraeckmansLaboratory of General Biochemistry and Physical Pharmacy, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, Ghent, 9000, Belgium.
Meng WangShenzhen University Medical School, Shenzhen University, Shenzhen, 518055, China.
Lin WangStephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, 73019, USA.
Wei R ChenStephenson School of Biomedical Engineering, University of Oklahoma, Norman, OK, 73019, USA.
Yunfei XiaState Key Laboratory of Oncology in South China, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, China. xiayf@sysucc.org.cn.
Zhilie TangGuangdong Basic Research Center of Excellence for Structure and Fundamental Interactions of Matter, Guangdong Provincial Key Laboratory of Quantum Engineering and Quantum Materials, School of Physics, South China Normal University, Guangzhou, 510006, China. tangzhl@scnu.edu.cn.
Xiaozhi XuGuangdong Basic Research Center of Excellence for Structure and Fundamental Interactions of Matter, Guangdong Provincial Key Laboratory of Quantum Engineering and Quantum Materials, School of Physics, South China Normal University, Guangzhou, 510006, China. xiaozhixu@scnu.edu.cn.

Funding

Guangdong Basic and Applied Basic Research Foundation 2022A1515110348Guangdong Natural Science Foundation 2022A1515011420the China Postdoctoral Science Foundation 2022M711223the National Natural Science Foundation of China 12322406the National Natural Science Foundation of China 61575067
6 · The paper itself

Abstract

backgroundPhotothermal immunotherapy, as a promising technique in cancer treatment, offering precise eradication of tumor tissue, minimal adverse effects, and reduced risk of recurrence and metastasis. However, due to the instability of tracer function after photothermal immunotherapy, the long-term in vivo tracing is still a significant challenge, thereby greatly impeding the comprehensive assessment of immune response and drug delivery outcomes.

resultsHere, we successfully demonstrated the feasibility of stable long-term in vivo immune tracking of photothermal immunodiagnosis and immunotherapy for breast cancer. The biocompatible and stable Ag

conclusionsThe results support that Ag

Indexed as

Breast NeoplasmsImmunotherapyPhototherapyPhotothermal TherapyQuantum DotsSilver CompoundsAnimalsCell Line, TumorFemaleHumansImiquimodMiceMice, Inbred BALB CImiquimodSilver Compoundssilver sulfideAg2S quantum dotsLong-term trackingPhotothermal immunotherapy

Identifiers

PMID40289132
PMCPMC12036159

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.